The case for adopting Neuropad to detect preclinical diabetic peripheral neuropathy is not supported by the evidence. Neuropad detects sub-normal sweating in patients with diabetes but the clinical importance of this in current NHS care pathways is poorly defined. There is insufficient evidence to suppor...
Farrell, B;
Black, C;
Thompson, W;
McCarthy, L;
Rojas-Fernandez, C;
Lochnan, H;
Shamji, S;
Upshur, R;
Bouchard, M;
Welch, V.
OBJECTIVE: To develop an evidence-based guideline to help clinicians make decisions about when and how to safely taper, stop, or switch antihyperglycemic agents in older adults. METHODS: We focused on the highest level of evidence available and sought input from primary care professionals in guideline de...
DESCRIPTION: In April 2017, the U.S. Department of Veterans Affairs (VA) and the U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of type 2 diabetes mellitus. METHODS: The VA/DoD Evidence-Based Practice Work Group convened a joint VA/DoD guideline developme...
Diabetes Mellitus Tipo 2,
Diabetes Mellitus,
Biomarcadores/sangre,
Glucemia/metabolismo,
Angiopatías Diabéticas/prevención & control,
Fructosamina/sangre,
Hemoglobina Glucada/metabolismo,
Hipoglucemiantes/uso terapéutico,
Esperanza de Vida,
Prioridad del Paciente,
Atención Dirigida al Paciente,
Hemoglobina Glucada,
Hipoglucemiantes
La Guía de Práctica Clínica (GPC) tiene como misión elaborar recomendaciones que sirvan de ayuda a los profesionales sanitarios del Sistema Nacional de Salud (SNS) en la toma de decisiones para el manejo de los lípidos como factor de Riesgo Cardiovascular. En esta GPC no se abordan los siguientes as...
Enfermedades Cardiovasculares/etiología,
Dieta/efectos adversos,
Carbohidratos de la Dieta/administración & dosificación,
Metabolismo de los Lípidos/fisiología,
Enfermedades Cardiovasculares/sangre,
Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico,
Ejercicio Físico/fisiología,
Diabetes Mellitus/etiología,
Carbohidratos de la Dieta/efectos adversos,
Grasas de la Dieta/administración & dosificación,
Grasas de la Dieta/efectos adversos,
Dislipidemias/etiología,
Dislipidemias/metabolismo,
Obesidad/complicaciones,
Obesidad/prevención & control,
Factores de Riesgo,
Enfoque GRADE,
Lípidos/sangre,
Biomarcadores/sangre
Hingorani, A;
LaMuraglia, G. M;
Henke, P;
Meissner, M. H;
Loretz, L;
Zinszer, K. M;
Driver, V. R;
Frykberg, R;
Carman, T. L;
Marston, W;
Mills, J. L;
Murad, M. H.
Diabetes mellitus continues to grow in global prevalence and to consume an increasing amount of health care resources. One of the key areas of morbidity associated with diabetes is the diabetic foot. To improve the care of patients with diabetic foot and to provide an evidence-based multidisciplinary man...
Brindar recomendaciones para la práctica clínica, basados en la mejor evidencia disponible para la atención en salud y utilización racional de recursos para el diagnóstico, tratamiento y seguimiento ambulatorio de pacientes con diabetes mellitus tipo 1, en la población mayor de 15 años....
Brindar recomendaciones para la práctica clínica, basados en la mejor evidencia disponible para la atención en salud y utilización racional de recursos para el diagnóstico, tratamiento y seguimiento ambulatorio de pacientes con diabetes mellitus tipo 1, en la población mayor de 15 años....
OBJECTIVE: To formulate clinical practice guidelines for the pharmacological management of obesity. PARTICIPANTS: An Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. This guideline was co-sponsored by the European Society of Endocrinology and The Obesity Society. ...
Evidence of benefits, harms, values and preferences, and cost effectiveness were reviewed in accordance with GRADE methods to determine the recommendation category (Ahmed F, Temte JL, Campos-Outcalt D, Schünemann HJ; for the ACIP Evidence Based Recommendations Work Group (EBRWG). Methods for developing ...
Intersecting epidemics Tuberculosis (TB) remains a considerable global public health concern, mainly affecting poor and vulnerable populations. Every year, more than 9 million people fall ill with this infectious disease, and close to 2 million die from it. Diabetes, a chronic metabolic disease that is i...
